Cartesian Therapeutics is a biotechnology company developing potent, safer cell and gene therapies for cancer and autoimmune diseases
Location: United States, Maryland, Gaithersburg
Investors 3
| Date | Name | Website |
| - | Schooner C... | schoonerca... |
| - | TEDCO | tedcomd.co... |
| - | BioHealth ... | biohealthi... |
Mentions in press and media 10
| Date | Title | Description |
| 08.01.2025 | Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report | Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today ... |
| 02.07.2024 | Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing | GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that it has enter... |
| 02.07.2024 | Cartesian Therapeutics Announces $130 Million Private Placement Equity Financing | GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that it has enter... |
| 02.07.2024 | Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout | Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout Tue, Jul 02, 2024 08:00 CET Report this content Sobi® today announced the initiation of a rolling Biologics Licen... |
| 08.03.2024 | CAR T-Cell Therapy Market Set for Healthy Growth after COVID19 Pandemic Top Players Industry Trends and Forecast 2032 | CHICAGO, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Global 𝐂𝐀𝐑 𝐓-𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭. This comprehen... |
| 07.03.2024 | Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update | - |
| 06.03.2024 | Cartesian Therapeutics to Participate in Upcoming Investor Conferences | - |
| 05.03.2024 | Cartesian Therapeutics Announces New Employment Inducement Grant | - |
| 05.03.2024 | Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, Maryland | - |
| 23.08.2022 | InstantGMP Inc. celebrates four years with Cartesian Therapeutics | InstantGMP™ celebrates four years of proudly supporting Cartesian Therapeutics’ groundbreaking work in the field of RNA cell therapy InstantGMP PRO allows us to move from preclinical development to clinical trials quickly,” Kalayoglu stated... |